Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (951-960 of 1,482) with videos related to

Pageof 149
Sort By:
American Journal of Hematology|May 22, 2025
A Phase 2 Trial of CPX-351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid LeukemiaTapan M Kadia, Wei-Ying Jen, Alex Bataller, et al.
Leukemia|May 9, 2025
Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangementsAlex Bataller, Hannah E Goulart, Ghayas C Issa, et al.
Blood Neoplasia|September 8, 2025
A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemiaAhmed Aribi, Gabriel N Mannis, Yazan F Madanat, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2016
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)Courtney D DiNardo, Sarah A Bannon, Mark Routbort, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 3, 2020
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1Andrés E Quesada, Guillermo Montalban-Bravo, Rajyalakshmi Luthra, et al.
Blood Cells, Molecules & Diseases|April 8, 2017
RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patientsMarcia R Dezan, Ingrid Helena Ribeiro, Valéria B Oliveira, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2024
TCA metabolism regulates DNA hypermethylation in LPS and <i>Mycobacterium tuberculosis</i>-induced immune toleranceAbhimanyu, Santiago Carrero Longlax, Tomoki Nishiguchi, et al.
Blood|July 13, 2023
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemiaJayastu Senapati, Samuel Urrutia, Sanam Loghavi, et al.
American Journal of Hematology|June 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapyAyalew Tefferi, Naseema Gangat, Aref Al-Kali, et al.
Journal of the Pediatric Infectious Diseases Society|May 20, 2025
Performance of a novel stool quantitative polymerase chain reaction assay for pediatric tuberculosis detection in sub-Saharan AfricaAnca Vasiliu, Lucia Carratala-Castro, Abigail Seeger, et al.
Pageof 149

Showing results (951-960 of 1,482) with videos related to

Sort By:
Pageof 149
American Journal of Hematology|May 22, 2025
A Phase 2 Trial of CPX-351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid LeukemiaTapan M Kadia, Wei-Ying Jen, Alex Bataller, et al.
Leukemia|May 9, 2025
Characteristics and outcomes of newly diagnosed acute myeloid Leukemia with KMT2A rearrangementsAlex Bataller, Hannah E Goulart, Ghayas C Issa, et al.
Blood Neoplasia|September 8, 2025
A phase 1 study of IO-202, an anti-LILRB4 antibody, in chronic myelomonocytic leukemia and acute myeloid leukemiaAhmed Aribi, Gabriel N Mannis, Yazan F Madanat, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 24, 2016
Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC)Courtney D DiNardo, Sarah A Bannon, Mark Routbort, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 3, 2020
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1Andrés E Quesada, Guillermo Montalban-Bravo, Rajyalakshmi Luthra, et al.
Blood Cells, Molecules & Diseases|April 8, 2017
RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patientsMarcia R Dezan, Ingrid Helena Ribeiro, Valéria B Oliveira, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 30, 2024
TCA metabolism regulates DNA hypermethylation in LPS and <i>Mycobacterium tuberculosis</i>-induced immune toleranceAbhimanyu, Santiago Carrero Longlax, Tomoki Nishiguchi, et al.
Blood|July 13, 2023
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemiaJayastu Senapati, Samuel Urrutia, Sanam Loghavi, et al.
American Journal of Hematology|June 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapyAyalew Tefferi, Naseema Gangat, Aref Al-Kali, et al.
Journal of the Pediatric Infectious Diseases Society|May 20, 2025
Performance of a novel stool quantitative polymerase chain reaction assay for pediatric tuberculosis detection in sub-Saharan AfricaAnca Vasiliu, Lucia Carratala-Castro, Abigail Seeger, et al.
Pageof 149